Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantP = 0.0921.8× alphagold
Moreover, IHC analysis revealed a borderline significant difference in the proportion of myeloid CD33 + cells in the tumor subgroups (Fisher's exact test; P = 0.092; Fig. 4B ), with the ECM3 + /IFN − subgroup comprising the lowest fraction of HGBCs classified in the CD33 low category, as well as the highest fraction of samples that did not express activation markers (such as PD‐1; Fig. 4C ).
borderline significantP = 0.0921.8× alphagold
Correlation analysis We determined that the average amplitudes of P3 evoked by inclusion were not significant and negatively correlated with BDI scales ( r = –0.234, P > 0.05), but were borderline significant and negatively correlated with the scores of anhedonia items ( r = –0.331, P = 0.092), which suggested that with higher scores of anhedonia items, P3 amplitudes would be lower.
borderline significantp = .0931.9× alphagold
Among job resources, high (vs low) social support significantly increased the likelihood of working longer, while the contribution of high (vs low) work-time control was borderline significant ( p = .093) in the adjusted model.
borderline significantp = 0.0931.9× alphagold
observed a borderline significant decrement in reclassification with the DOAC score relative to the ORBIT score for major bleeding, with an NRI of –11.2% (95% CI, –26.2% to 0.8%; p = 0.093) and an IDI of –1.2% (95% CI, –2.5% to 0%; p = 0.004), while no improvement was noted compared with HAS‐BLED.
borderline significantp = 0.0931.9× alphagold
For GALNT2 , an average but borderline significant 0.52 mmol/L HDLc increase was observed in 10 total GALNT2 mutation carriers vs. 11 first-degree controls (+34.2%, p = 0.093), suggesting that either GALNT2 mutations have weaker or more variable effects than LIPG and CETP mutations on HDLc elevation and/or these families have insufficient power for detecting significant GALNT2 mutation associations with increased HDLc.